Week 1 Flashcards

1
Q

Agonist

A

A drug that binds to and activates a receptor. Can be full, partial or inverse. A full agonist has high efficacy, producing a full response while occupying a relatively low proportion of receptors. A partial agonist has lower efficacy than a full agonist. It produces sub-maximal activation even when occupying the total receptor population, therefore cannot produce the maximal response, irrespective of the concentration applied. An inverse agonist produces an effect opposite to that of an agonist, yet it binds to the same receptor binding-site as an agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Efficacy

A

Describes the way that agonists vary in the response they produce when they occupy the same number of receptors. High efficacy agonists produce their maximal response while occupying a relatively low proportion of the total receptor population. Lower efficacy agonists do not activate receptors to the same degree and may not be able to produce the maximal response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Potency

A

A measure of the concentrations at which a drug is effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Desensitization

A

A reduction in response to an agonist while it is continuously present at the receptor, or progressive decrease in response upon repeated exposure to an agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Duration of Action

A

The length of time that particular drug is effective. Duration of action is a function of several parameters including plasma half-life, the time to equilibrate between plasma and target compartments, and the off rate of the drug from its biological target.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Silent Antagonist

A

A drug that attenuates the effects of agonists or inverse agonists, producing a functional reduction in signal transduction. Affects only ligand-dependent receptor activation and displays no intrinsic activity itself. Also known as a neutral antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Half-life

A

The metabolic half-life of a drug in vivo is the time taken for its concentration in plasma to decline to half its original level. Half-life refers to the duration of action of a drug and depends upon how quickly the drug is eliminated from the plasma. The clearance and distribution of a drug from the plasma are therefore important parameters for the determination of its half-life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of action

A

Refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Therapeutic Window

A

The amount of a medication between the amount that gives an effect (effective dose) and the amount that gives more adverse effects than desired effects. For instance, medication with a small pharmaceutical window must be administered with care and control, e.g. by frequently measuring blood concentration of the drug, since it easily loses effects or gives adverse effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

B Max

A

The maximum amount of drug which can bind specifically to the receptors in a membrane preparation. Can be used to measure the density of the receptor site in a particular preparation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What schedule drugs can APRNs prescribe?

A

Schedule II, III, IV and V drugs.

Schedule I drugs have no medical use and high potential for abuse (heroin, ecstasy, marijuana etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharmacokinetics

A

The study of drug movement through the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharmacodynamics

A

The study of the biochemical and physiological effects of drugs on the body and molecular mechanisms by which those effects are produced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Basic processes of Pharmacokinetics

A
  1. Absorption
  2. Distribution
  3. Metabolism
  4. Excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Absorption

A

A drug’s movement from the site of administration into the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Distribution

A

A drug’s movement from the site of administration into the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Metabolism

A

aka - biotransformation

Enzymatically mediated alteration of drug structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Excretion

A

The movement of drugs and their metabolites out of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CYP450

A

Liver enzyme that metabolizes drugs which can be inhibited or induced by drugs and when this happens drug-drug interactions occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Who determines prescriptive authority?

A

Determined by state law.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Who regulates prescriptive authority?

A

Under the jurisdiction of a professional health board (Nursing, medicine, pharmacy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How does limited prescriptive authority impact patients within the healthcare system?

A

Creates barriers to quality, affordable, accessible patient care.

May prevent outreach to areas of greatest need (NP needs MD and none in the area)

Can increase prescription wait time (cosigning)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the key responsibilities of prescribing?

A

Having a sound understanding of drugs and the condition they are used to manage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What elements should be used to make prescribing decisions?

A

o Cost
o Current treatment guidelines
o Availability of medication
o Interactions with other medications
o Side effects
o Allergies
o Hepatic and renal function
o Need for monitoring
o Special populations (children and the elderly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Pharmacokinetic changes in older adults

A
  • Decreased ability of the liver to metabolize drugs
  • higher concentration of drugs in the blood
  • Decreased kidney function to excrete drugs - they stay in the bloodstream longer
  • Increased drug sensitivity (reduced hepatic and renal elimination)
  • Potential for increased variability in drug function
  • potential for more intense effects
  • need to reduce dosages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Older adults - changes in drug absorption

A

Slower rate of absorption, delayed drug response, gastric acidity may alter absorption
* Increased gastric pH
* Decreased surface area for absorption
* Decreased GI motility
* Delayed gastric emptying
* Decreased splanchnic blood floor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Older adults - changes in drug distribution

A
  • Increased body fat  reduced response to lipid soluble drugs
  • Decreased lean mass
  • Decreased total water  lower distribution of water soluble drugs
  • Decreased serum albumin  decreased binding sites, more drug in the blood – higher intensity drug effect
  • Decreased CO
28
Q

Older adults - changes in drug metabolism

A

Increased drug half-life, prolonged medication response due to slower metabolism of drugs.
* Decreased hepatic blood flow
* Decreased hepatic mass
* Decreased activity of hepatic enzymes

29
Q

Older adults - changes in drug excretion

A

Drug accumulation secondary to reduced renal excretion (causes adverse drug reactions)
* Decreased renal blood flow
* Decreased GFR
* Decreased tubular secretion
* Decreased number of nephrons

30
Q

Beers Criteria

A

Identifies drugs with a high likelihood of causing adverse effects in older adults. Accordingly, drugs on this list should generally be avoided in adults older than 65 years except when the benefits are significantly greater than the risks

31
Q

Impact/Outcomes of Polypharmacy

A

o Higher risk for drug interactions and adverse reactions
o More difficulty with medication adherence

32
Q

Examples of CYP450 Inhibitors

A

 Valproate
 Isoniazid
 Sulfonamides
 Amiodarone
 Chloramphenicol
 Ketoconazole
 Grapefruit juice
 Quinidine

VISA debt inhibits spending on CK to look GQ

33
Q

Function of CYP450 inhibitors

A

Act on the liver to slow the rate of metabolism causing an increase in active drug accumulation in the blood. This can lead to increased adverse effects and toxicity.

34
Q

What do CYP450 inhibitors cause if not used correctly? (aka: What would the patient experience?)

A

The inhibiting drug inhibits metabolism of the second drug which can be beneficial but more often causes toxicity or adverse reactions.

35
Q

Examples of CYP450 inducers

A

 Barbiturates
 St. john’s wort
 Carbamazepine
 Rifampin
 Alcohol
 Phenytoin
 Griseofulvin
 Phenobarbital
 Sulfonylureas

BS CRAP GPS induces RAGE

36
Q

Function of CYP450 inducers

A

Inducers act on the liver to stimulate enzyme synthesis. By increasing the rate of drug metabolism the amount of active drugs is decreased and plasma levels fall. This may result in medication not achieving therapeutic levels.

37
Q

Function of CYP450 inducers

A

Inducers act on the liver to stimulate enzyme synthesis. By increasing the rate of drug metabolism the amount of active drugs is decreased and plasma levels fall. This may result in medication not achieving therapeutic levels.

38
Q

What do inducers cause if not used correctly? (aka: What would the patient experience?)

A
  • Medication taken along with an inducer would need its dosage increased to be effective.
  • When an inducer is discontinued dosages of other drugs need to be lowered to avoid dangerous high drug levels.
39
Q

What happens when someone has a poor metabolism phenotype?

A

The poor metabolism of drugs can reduce the benefits of therapy by being unable to activate medication through metabolism into its active form causing treatment to fail.

Poor metabolism can cause the standard dose of a medication to accumulate to high levels in the blood causing toxicity.

40
Q

What does the U.S. Food and Drug Administration regulate when it comes to medications?

A

Regulates the safety and effectiveness of drugs sold in the united states

41
Q

Reasons for medication non-adherence

A

o Forgetfulness
o Lack of planning
o Cost
o Dissatisfaction
o Altered dosing

42
Q

What are black box warnings?

A

 Strongest safety warning a drug can have and still remain on the market. They alert the provider to:
* Potentially severe side effects (life threatening dysrhythmias, suicidality, fetal harm)
* Ways to prevent or reduce harm
 Contain a summary of the adverse effects of concern

43
Q

Why are black box warnings issued?

A

To alert the patient and provider to the risk of harm from taking the medication

44
Q

Neonate and infant drug absorption

(general development and when absorption would reach adults levels)

A

 Kidneys don’t fully develop until a few months after birth meaning they have a limited capacity to excrete drugs
 Gastric emptying is prolonged and irregular and reaches adult level by 6-8 months old
 Delayed absorption in the intestine due to delayed gastric emptying
 Gastric acidity is low and does not reach adult values for 2 years.  absorption of acid-labile drugs is increased
 Transdermal absorption is increased due to thin skin and higher blood flow
 Blood brain barrier not fully developed
 Hepatic metabolism is low – complete maturation of liver by 1 year old
 Renal excretion – renal blood flow, GFR and active tubular secretion are low – like adults by 1 year old.

45
Q

Common fears with genetic testing

A

o Financial cost
o Fear of results
o Fear of discrimination based on results

46
Q

What are some of the physiologic changes that occur in the body when a woman is pregnant that can change the pharmacodynamic and pharmacokinetic properties of many drugs?

A

o Increased GFR increases excretion
o Slower digestion
o Decreased tone and mobility of bowel
o Increase hepatic metabolism of some drugs

47
Q

During what trimester is a pregnant woman most at risk for adverse drug reactions with potential long-term consequences?

A

First trimester (fetus most at risk due to rapid growth)

48
Q

What medications do we know are teratogenic?

A

o Hormonal
o Antidepressant
o Antibiotic
o Antiepileptic drugs

49
Q

How is absorption of intramuscular medication different in neonates?

A

Decreased absorption due to low blood flow in the muscles due in the first few days of life.

50
Q

Why is absorption of medication in the stomach increased in infancy?

A

Delayed gastric emptying until 6-8 months causes increased absorption

51
Q

What are some medications that should be avoided in the pediatric patient?

A

o Aspirin
o Tetracycline (discoloration of teeth)
o Antibiotics
o Sulfonamides
o Glucocorticoids
o Levofloxacin (spontaneous tendon rupture)

52
Q

What should be included in medication administration patient education?

A

Dosing, route, how often to take, how long to take, side effects, drug storage, desired response and adverse reactions

53
Q

What are some things that put elderly patients at higher risk for adverse drug reactions?

A

o Reduced renal function
o Polypharmacy (5+ medications on a daily basis)
o Comorbidities
o Decreased liver function
o Greater severity of illness
o Patient adherence
o Inadequate supervision of long-term therapy

54
Q

How can we as healthcare providers decrease the likelihood of an elderly patient experiencing an adverse drug reaction?

A

o Complete medication/medical history
o Medication review yearly
o Encouraging the use of one pharmacy
o Lab values
o Look at drug interactions when prescribing new drugs
o Consider change with age (adjust dosing)
o BEERS criteria list

55
Q

How can we promote medication adherence with our elderly patients?

A

o Explain the importance/purpose of medications
o Include family members
o Try to make dosing easy - simplify regimen
 Pill dispenser
o Being aware of cost
o Clearly labeled/ easy to open
o Support system

56
Q

Why do nitrates need to be taken no later than 4 pm?

A

You need a nitrate free interval so that a tolerance doesn’t develop (8 hours usually overnight)

57
Q

What are the nine factors that impact the outcome of medication according to Rosenthal and Burcham?

A

o Genetics
o Pharmacogenomics
o Gender
o Race
o Body weight
o Age
o Tolerance
o Placebo effect
o Pathophysiology of medication

58
Q

Do we need informed consent for genetic testing?

A

Yes

59
Q

What is the purpose of the Genetic Information Non-Discriminatory Act?

A

o To prevent discrimination based on genetic predisposition
o Protects the patient from discrimination by employers and insurers

60
Q

What is the difference between NP practice authority and prescriptive authority?

A

o Practice authority is whether you can practice without physician oversight
o Prescriptive authority is the ability to write prescriptions independently

61
Q

What is full practice authority?

A

Ability to practice independently (assess, diagnose, evaluate, treat) without physician oversight

62
Q

What is reduced practice authority?

A

o Able to practice with oversight from a physician
o Provider for first 5 years then independently
o Willing to have practitioner to
o Limited in at least one area of practice
o Collaborative agreement with a licensed provider

63
Q

What is restricted practice authority?

A

Need a doctor on site and available

64
Q

What are the components of an Rx?

A

o Patient information
o Provider information
o Name of drug
o Dose of drug
o Route of administration
o Dose frequency
o Refills
o Quantity
o Directions for use

65
Q

What are some potential problems that may arise with written prescriptions?

A

o legibility
o incorrect abbreviations
o misspelling
o don’t contain all elements
o tamper resistant scripts

66
Q

What are some reasons for monitoring drug therapy?

A

o Assess effects – is it therapeutic
o Adverse reactions
o Checking for abuse